The Impact of Palm Date Intake on Colon Health Biomarkers (AJWA)
A Randomised, Controlled Intervention Trial to Assess the Impact of Palm Date Intake on Markers of Large Intestinal Health
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Signed consent form
- Body mass index - 18.5 - 30 inclusive
- Age 18 - 55 years
- Good general health as determined by medical questionnaires Requirements for diet and medication during study
- No intake of additional supplementary prebiotics (i.e. such as fructo-oligosaccharides) - please note that consumption of foods that are naturally prebiotic, e.g. cereal grains and leeks, may be consumed as normal
- No intake of probiotics (i.e. live yoghurts), drugs active on gastrointestinal motility, antibiotic treatment or any class of laxative
- All concomitant medication must be recorded in diaries and case record forms
- Usual diet, fluid intake and exercise levels should be maintained during trial period
- Please inform the investigator if you consume antibiotics during the trial. You will not be able to continue, as this may affect your faecal bacteria.
Exclusion Criteria:
- Requirements to take long-term medication active on the gastro-intestinal tract
- Use of antibiotics within the previous 6 months
- Anaemia
- Diabetes mellitus
- History of alcohol or drug abuse
- Current smoker
- Intake of any experimental drug within 4 weeks of the start of the study
- Excessive alcohol consumption (more than 21 units/wk male, 14 units/wk female)
- Females who are breast-feeding, may be pregnant, or if of child-bearing potential and are not using effective contraceptive precautions
- Major surgery, which might limit participation in, or completion of, the study.
- Participation in a study involving prebiotics or probiotics within the previous 3 months
- Physical or mental diseases that are likely to limit participation or completion of the study
- Severe allergy to foods or severe abnormal drug reactions
- Chronic gastroenterological complaints
- Intake of other supplementary prebiotics or probiotics, drugs active on gastrointestinal motility, or a laxative of any class during or within the four weeks prior to the start of the study
- Aged below 18 or over 55 years
- Have a BMI of less than 18.5 or more than 30
- Gluten allergy
- Calorie restriction or other special diet (e.g. Atkins diet, montignac diet) 6 weeks prior to the start of the study
- Vaccination against with the current season's influenza and AH1N1 flu
- Manifestation of allergy, asthma and dermatitis
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Maltodextrin/Dextrose mix
Twenty-two healthy human individuals were randomly assigned to consume a control (maltodextrin-dextrose, 40.2g) at one of the arms period. Each arm was 21 days in duration, separated by a 14 days washout period. P.S. placebo is called control in this study, where the bioactive comparator is a fruit. |
Twenty-two healthy human individuals were randomly assigned to consume 7 date fruits (approx.
50g).
Each arm was 21 days in duration, separated by a 14 days washout period.
Other Names:
|
|
Active Comparator: Date fruit - Ajwa variety
Twenty-two healthy human individuals were randomly assigned to consume date fruits (approx.
50g) at one of the arms period.
Each arm was 21 days in duration, separated by a 14 days washout period.
|
Twenty-two healthy human individuals were randomly assigned to consume Maltodextrin/dextrose , 40.2g.
Each arm was 21 days in duration, separated by a 14 days washout period.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in large intestinal microbiota composition verses control intervention (0-3 months)
Time Frame: 3 months
|
Microbial profile assessed by FISH
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in Bowel function verses the control intervention (0-3 months
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: JEREMY PE SPENCER, PhD, UNIVERSITY OF READING - FOOD AND NUTRITIONAL SCIENCES DEPARTMENT
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AJWA STUDY
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.